HEADER FLAVOPROTEIN 03-SEP-08 3EDO TITLE CRYSTAL STRUCTURE OF FLAVOPROTEIN IN COMPLEX WITH FMN (YP_193882.1) TITLE 2 FROM LACTOBACILLUS ACIDOPHILUS NCFM AT 1.20 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PUTATIVE TRP REPRESSOR BINDING PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: FLAVOPROTEIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: LACTOBACILLUS ACIDOPHILUS NCFM; SOURCE 3 ORGANISM_TAXID: 272621; SOURCE 4 GENE: YP_193882.1, LBA1001; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS YP_193882.1, FLAVOPROTEIN IN COMPLEX WITH FMN, STRUCTURAL GENOMICS, KEYWDS 2 JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE KEYWDS 3 INITIATIVE, PSI-2, FLAVOPROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 5 01-FEB-23 3EDO 1 REMARK SEQADV REVDAT 4 24-JUL-19 3EDO 1 REMARK LINK REVDAT 3 25-OCT-17 3EDO 1 REMARK REVDAT 2 24-FEB-09 3EDO 1 VERSN REVDAT 1 30-SEP-08 3EDO 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF FLAVOPROTEIN IN COMPLEX WITH FMN JRNL TITL 2 (YP_193882.1) FROM LACTOBACILLUS ACIDOPHILUS NCFM AT 1.20 A JRNL TITL 3 RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.42 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 114155 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.137 REMARK 3 R VALUE (WORKING SET) : 0.136 REMARK 3 FREE R VALUE : 0.160 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 5724 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.23 REMARK 3 REFLECTION IN BIN (WORKING SET) : 7795 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.26 REMARK 3 BIN R VALUE (WORKING SET) : 0.2220 REMARK 3 BIN FREE R VALUE SET COUNT : 377 REMARK 3 BIN FREE R VALUE : 0.2470 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2371 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 94 REMARK 3 SOLVENT ATOMS : 594 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 10.26 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 15.84 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.42000 REMARK 3 B22 (A**2) : 0.36000 REMARK 3 B33 (A**2) : -0.77000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.034 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.034 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.021 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.039 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.978 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.972 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2712 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1837 ; 0.003 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3710 ; 1.422 ; 1.986 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4540 ; 0.868 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 359 ; 5.973 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 123 ;37.761 ;25.935 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 485 ;10.352 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 6 ; 7.800 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 398 ; 0.089 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3017 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 511 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 514 ; 0.220 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 1938 ; 0.182 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1347 ; 0.188 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1305 ; 0.087 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 456 ; 0.161 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 21 ; 0.277 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 69 ; 0.301 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 53 ; 0.205 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1659 ; 1.465 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 644 ; 0.649 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2603 ; 2.014 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1323 ; 2.711 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1078 ; 3.807 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 5256 ; 1.360 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 616 ; 7.014 ; 3.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 4469 ; 3.719 ; 3.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1.HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. 2.A MET-INHIBITION PROTOCOL WAS USED FOR REMARK 3 SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE REMARK 3 OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO REMARK 3 0.75 TO ACCOUNT FOR THE REDUCED SCATTERING POWER DUE TO REMARK 3 PARTIAL S-MET INCORPORATION. 3.ETHYLENE GLYCOL MOLECULES FROM CRYO REMARK 3 CONDITION ARE MODELED INTO THE STRUCTURE. 4. ELECTRON DENSITIES AT REMARK 3 AMINO ACID MSE 46 ON THE TWO NCS-RELATED SUBUNITS INDICATED THE REMARK 3 SIDECHAINS OF THESE TWO RESIDUES TO BE MODIFIED. THEREFORE THESE REMARK 3 TWO RESISUES WERE MODELED AS SELENOMETHIONINE SELENOXIDE (MSO) REMARK 4 REMARK 4 3EDO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-SEP-08. REMARK 100 THE DEPOSITION ID IS D_1000049192. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-MAY-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97910 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL SI(111) BENT REMARK 200 MONOCHROMATOR (HORIZONTAL REMARK 200 FOCUSING) REMARK 200 OPTICS : FLAT MIRROR (VERTICAL FOCUSING) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 114258 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.200 REMARK 200 RESOLUTION RANGE LOW (A) : 29.424 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.24 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.4 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.45900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2000M NH4H2PO3, 20.0000% PEG-3350, REMARK 280 NO BUFFER PH 4.6, NANODROP, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.28000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 78.37500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 26.01500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 78.37500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.28000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 26.01500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: AUTHORS STATE THAT SIZE EXCLUSION CHROMATOGRAPHY SUPPORTS REMARK 300 THE ASSIGNMENT OF A MONOMER AS A SIGNIFICANT OLIGOMERIZATION STATE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY B 0 REMARK 465 MSE B 1 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MSE A 1 CG SE CE REMARK 470 LYS A 28 CE NZ REMARK 470 LYS A 33 CE NZ REMARK 470 LYS A 36 NZ REMARK 470 GLU A 39 OE1 OE2 REMARK 470 LYS A 102 CD CE NZ REMARK 470 LYS A 120 NZ REMARK 470 LYS B 28 CG CD CE NZ REMARK 470 GLU B 39 CD OE1 OE2 REMARK 470 LYS B 102 CD CE NZ REMARK 470 LYS B 120 NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O2 EDO A 205 O HOH A 285 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 42 -150.54 -113.86 REMARK 500 ASP A 141 -138.33 53.50 REMARK 500 PHE B 42 -131.72 -113.69 REMARK 500 ASP B 141 -138.02 52.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FMN A 200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FMN B 200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 204 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 205 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 206 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 388454 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 SEQUENCE THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE, LEAVING REMARK 999 ONLY A GLYCINE, FOLLOWED BY THE TARGET SEQUENCE DBREF 3EDO A 1 150 UNP Q5FKC3 Q5FKC3_LACAC 1 150 DBREF 3EDO B 1 150 UNP Q5FKC3 Q5FKC3_LACAC 1 150 SEQADV 3EDO GLY A 0 UNP Q5FKC3 EXPRESSION TAG SEQADV 3EDO GLY B 0 UNP Q5FKC3 EXPRESSION TAG SEQRES 1 A 151 GLY MSE ALA LYS LYS THR LEU ILE LEU TYR TYR SER TRP SEQRES 2 A 151 SER GLY GLU THR LYS LYS MSE ALA GLU LYS ILE ASN SER SEQRES 3 A 151 GLU ILE LYS ASP SER GLU LEU LYS GLU VAL LYS VAL SER SEQRES 4 A 151 GLU GLY THR PHE ASP ALA ASP MSO TYR LYS THR SER ASP SEQRES 5 A 151 ILE ALA LEU ASP GLN ILE GLN GLY ASN LYS ASP PHE PRO SEQRES 6 A 151 GLU ILE GLN LEU ASP ASN ILE ASP TYR ASN ASN TYR ASP SEQRES 7 A 151 LEU ILE LEU ILE GLY SER PRO VAL TRP SER GLY TYR PRO SEQRES 8 A 151 ALA THR PRO ILE LYS THR LEU LEU ASP GLN MSE LYS ASN SEQRES 9 A 151 TYR ARG GLY GLU VAL ALA SER PHE PHE THR SER ALA GLY SEQRES 10 A 151 THR ASN HIS LYS ALA TYR VAL SER HIS PHE ASN GLU TRP SEQRES 11 A 151 ALA ASP GLY LEU ASN VAL ILE GLY VAL ALA ARG ASP ASP SEQRES 12 A 151 SER GLU VAL ASP LYS TRP SER LYS SEQRES 1 B 151 GLY MSE ALA LYS LYS THR LEU ILE LEU TYR TYR SER TRP SEQRES 2 B 151 SER GLY GLU THR LYS LYS MSE ALA GLU LYS ILE ASN SER SEQRES 3 B 151 GLU ILE LYS ASP SER GLU LEU LYS GLU VAL LYS VAL SER SEQRES 4 B 151 GLU GLY THR PHE ASP ALA ASP MSO TYR LYS THR SER ASP SEQRES 5 B 151 ILE ALA LEU ASP GLN ILE GLN GLY ASN LYS ASP PHE PRO SEQRES 6 B 151 GLU ILE GLN LEU ASP ASN ILE ASP TYR ASN ASN TYR ASP SEQRES 7 B 151 LEU ILE LEU ILE GLY SER PRO VAL TRP SER GLY TYR PRO SEQRES 8 B 151 ALA THR PRO ILE LYS THR LEU LEU ASP GLN MSE LYS ASN SEQRES 9 B 151 TYR ARG GLY GLU VAL ALA SER PHE PHE THR SER ALA GLY SEQRES 10 B 151 THR ASN HIS LYS ALA TYR VAL SER HIS PHE ASN GLU TRP SEQRES 11 B 151 ALA ASP GLY LEU ASN VAL ILE GLY VAL ALA ARG ASP ASP SEQRES 12 B 151 SER GLU VAL ASP LYS TRP SER LYS MODRES 3EDO MSE A 1 MET SELENOMETHIONINE MODRES 3EDO MSE A 19 MET SELENOMETHIONINE MODRES 3EDO MSO A 46 MET SELENOMETHIONINE SELENOXIDE MODRES 3EDO MSE A 101 MET SELENOMETHIONINE MODRES 3EDO MSE B 19 MET SELENOMETHIONINE MODRES 3EDO MSO B 46 MET SELENOMETHIONINE SELENOXIDE MODRES 3EDO MSE B 101 MET SELENOMETHIONINE HET MSE A 1 5 HET MSE A 19 8 HET MSO A 46 9 HET MSE A 101 8 HET MSE B 19 13 HET MSO B 46 9 HET MSE B 101 8 HET FMN A 200 31 HET EDO A 201 4 HET EDO A 202 4 HET EDO A 203 4 HET EDO A 204 4 HET EDO A 205 4 HET EDO A 206 4 HET FMN B 200 31 HET EDO B 201 4 HET EDO B 202 4 HETNAM MSE SELENOMETHIONINE HETNAM MSO SELENOMETHIONINE SELENOXIDE HETNAM FMN FLAVIN MONONUCLEOTIDE HETNAM EDO 1,2-ETHANEDIOL HETSYN FMN RIBOFLAVIN MONOPHOSPHATE HETSYN EDO ETHYLENE GLYCOL FORMUL 1 MSE 5(C5 H11 N O2 SE) FORMUL 1 MSO 2(C5 H11 N O3 SE) FORMUL 3 FMN 2(C17 H21 N4 O9 P) FORMUL 4 EDO 8(C2 H6 O2) FORMUL 13 HOH *594(H2 O) HELIX 1 1 GLY A 14 ILE A 27 1 14 HELIX 2 2 ASP A 45 GLN A 58 1 14 HELIX 3 3 ASP A 72 TYR A 76 5 5 HELIX 4 4 THR A 92 MSE A 101 1 10 HELIX 5 5 ASN A 118 ALA A 130 1 13 HELIX 6 6 GLU A 144 LYS A 150 1 7 HELIX 7 7 GLY B 14 ILE B 27 1 14 HELIX 8 8 ASP B 45 GLN B 58 1 14 HELIX 9 9 ASP B 72 TYR B 76 5 5 HELIX 10 10 ALA B 91 MSE B 101 1 11 HELIX 11 11 ASN B 118 ALA B 130 1 13 HELIX 12 12 GLU B 144 LYS B 150 1 7 SHEET 1 A 4 GLU A 31 GLU A 34 0 SHEET 2 A 4 THR A 5 TYR A 9 1 N ILE A 7 O GLU A 31 SHEET 3 A 4 LEU A 78 TRP A 86 1 O LEU A 80 N LEU A 8 SHEET 4 A 4 TYR A 89 PRO A 90 -1 O TYR A 89 N TRP A 86 SHEET 1 B 5 GLU A 31 GLU A 34 0 SHEET 2 B 5 THR A 5 TYR A 9 1 N ILE A 7 O GLU A 31 SHEET 3 B 5 LEU A 78 TRP A 86 1 O LEU A 80 N LEU A 8 SHEET 4 B 5 GLU A 107 THR A 113 1 O ALA A 109 N ILE A 81 SHEET 5 B 5 ASN A 134 ARG A 140 1 O ILE A 136 N VAL A 108 SHEET 1 C 4 GLU B 31 GLU B 34 0 SHEET 2 C 4 THR B 5 TYR B 9 1 N ILE B 7 O GLU B 31 SHEET 3 C 4 LEU B 78 TRP B 86 1 O LEU B 80 N LEU B 8 SHEET 4 C 4 TYR B 89 PRO B 90 -1 O TYR B 89 N TRP B 86 SHEET 1 D 5 GLU B 31 GLU B 34 0 SHEET 2 D 5 THR B 5 TYR B 9 1 N ILE B 7 O GLU B 31 SHEET 3 D 5 LEU B 78 TRP B 86 1 O LEU B 80 N LEU B 8 SHEET 4 D 5 GLU B 107 THR B 113 1 O ALA B 109 N ILE B 81 SHEET 5 D 5 ASN B 134 ARG B 140 1 O ILE B 136 N VAL B 108 LINK C GLY A 0 N MSE A 1 1555 1555 1.33 LINK C MSE A 1 N ALA A 2 1555 1555 1.34 LINK C LYS A 18 N MSE A 19 1555 1555 1.33 LINK C MSE A 19 N ALA A 20 1555 1555 1.32 LINK C ASP A 45 N MSO A 46 1555 1555 1.33 LINK C MSO A 46 N TYR A 47 1555 1555 1.33 LINK C GLN A 100 N MSE A 101 1555 1555 1.33 LINK C MSE A 101 N LYS A 102 1555 1555 1.33 LINK C LYS B 18 N MSE B 19 1555 1555 1.32 LINK C MSE B 19 N ALA B 20 1555 1555 1.32 LINK C ASP B 45 N MSO B 46 1555 1555 1.32 LINK C MSO B 46 N TYR B 47 1555 1555 1.33 LINK C GLN B 100 N MSE B 101 1555 1555 1.33 LINK C MSE B 101 N LYS B 102 1555 1555 1.34 SITE 1 AC1 24 SER A 11 TRP A 12 SER A 13 GLY A 14 SITE 2 AC1 24 GLU A 15 THR A 16 PRO A 84 VAL A 85 SITE 3 AC1 24 TRP A 86 SER A 87 GLY A 88 THR A 113 SITE 4 AC1 24 SER A 114 ALA A 115 GLY A 116 THR A 117 SITE 5 AC1 24 ASN A 118 EDO A 203 HOH A 207 HOH A 254 SITE 6 AC1 24 HOH A 307 HOH A 409 TYR B 47 HOH B 229 SITE 1 AC2 24 TYR A 47 HOH A 272 SER B 11 TRP B 12 SITE 2 AC2 24 SER B 13 GLY B 14 GLU B 15 THR B 16 SITE 3 AC2 24 PRO B 84 VAL B 85 TRP B 86 SER B 87 SITE 4 AC2 24 GLY B 88 THR B 113 SER B 114 ALA B 115 SITE 5 AC2 24 GLY B 116 THR B 117 ASN B 118 EDO B 201 SITE 6 AC2 24 HOH B 211 HOH B 212 HOH B 317 HOH B 430 SITE 1 AC3 6 GLY A 0 MSE A 1 SER A 149 LYS A 150 SITE 2 AC3 6 HOH A 257 HOH A 495 SITE 1 AC4 5 GLU A 26 ASP A 146 HOH A 246 ASP B 43 SITE 2 AC4 5 LYS B 48 SITE 1 AC5 5 SER A 50 SER A 87 FMN A 200 HOH A 262 SITE 2 AC5 5 HOH A 487 SITE 1 AC6 5 SER B 50 SER B 87 FMN B 200 HOH B 269 SITE 2 AC6 5 HOH B 288 SITE 1 AC7 7 ASP A 146 SER A 149 HOH A 217 HOH A 240 SITE 2 AC7 7 HOH A 258 GLY B 40 HOH B 257 SITE 1 AC8 8 SER A 114 SER A 124 HIS A 125 GLU A 128 SITE 2 AC8 8 ARG A 140 HOH A 209 HOH A 260 HOH A 350 SITE 1 AC9 9 TYR A 89 ARG A 140 ASP A 141 HOH A 224 SITE 2 AC9 9 HOH A 260 HOH A 285 HOH A 289 HOH A 332 SITE 3 AC9 9 HOH A 452 SITE 1 BC1 8 ASN A 74 TYR A 76 ARG A 105 GLY A 106 SITE 2 BC1 8 HOH A 314 HOH A 485 ARG B 105 HOH B 460 CRYST1 44.560 52.030 156.750 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022442 0.000000 0.000000 0.00000 SCALE2 0.000000 0.019220 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006380 0.00000